These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28028356)

  • 21. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5.
    Schlicker C; Gertz M; Papatheodorou P; Kachholz B; Becker CF; Steegborn C
    J Mol Biol; 2008 Oct; 382(3):790-801. PubMed ID: 18680753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats].
    Chen LL; Deng XQ; Li NX
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1434-7. PubMed ID: 17785073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin and sirtuins: A "not-so unexpected" relationship.
    Mayo JC; Sainz RM; González Menéndez P; Cepas V; Tan DX; Reiter RJ
    J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 28109165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of nuclear sirtuins: molecular mechanisms and physiological relevance.
    Toiber D; Sebastian C; Mostoslavsky R
    Handb Exp Pharmacol; 2011; 206():189-224. PubMed ID: 21879451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats.
    Chen YR; Fang SR; Fu YC; Zhou XH; Xu MY; Xu WC
    Biochem Cell Biol; 2010 Aug; 88(4):715-22. PubMed ID: 20651844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
    Schemies J; Uciechowska U; Sippl W; Jung M
    Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
    Gertz M; Steegborn C
    Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
    Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
    Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirtuins, Cell Senescence, and Vascular Aging.
    Kida Y; Goligorsky MS
    Can J Cardiol; 2016 May; 32(5):634-41. PubMed ID: 26948035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of histone deacetylase on nonalcoholic fatty liver disease.
    Fu S; Yu M; Tan Y; Liu D
    Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):353-361. PubMed ID: 33213187
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirtuins in vascular diseases: Emerging roles and therapeutic potential.
    D'Onofrio N; Vitiello M; Casale R; Servillo L; Giovane A; Balestrieri ML
    Biochim Biophys Acta; 2015 Jul; 1852(7):1311-22. PubMed ID: 25766107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis.
    Sosnowska B; Mazidi M; Penson P; Gluba-Brzózka A; Rysz J; Banach M
    Atherosclerosis; 2017 Oct; 265():275-282. PubMed ID: 28870631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Modulation of Sirtuins by Oxidative Stress.
    Santos L; Escande C; Denicola A
    Oxid Med Cell Longev; 2016; 2016():9831825. PubMed ID: 26788256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections.
    Alqarni MH; Foudah AI; Muharram MM; Labrou NE
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.